Artificial intelligence is innovating the standards in cancer treatment, and the investments keep flowing for those solutions leveraging AI in oncology. However, the adoption rate of these solutions is still questionable. There are at least 4 ways to increase adoption.
DTx solutions have raised significant awareness and funding over the last few years. Still, business and population health impact are limited. To unlock the full potential of DTx solutions, 5 main obstacles must be overcome.